Target intelligence / Profile preview

Purine nucleoside phosphorylase DeoD-type (PNP (DeoD-type), PNP)

Target
PNP (DeoD-type), PNP
Molecular classification
Enzyme
01

Overview

Purine nucleoside phosphorylase DeoD-type is a **bacterial enzyme**, exemplified in species like *Escherichia coli* and *Bacillus anthracis*, that catalyzes the reversible phosphorolysis of the N-glycosidic bond in beta-(deoxy)ribonucleosides, producing corresponding purine bases and pentose-1-phosphate[2][3][5]. It functions in the **purine salvage pathway**, is hexameric (with multiple active sites per dimer), and is critical for bacterial nucleoside metabolism and survival[3]. Differences between bacterial and human PNP enable its use in **antibacterial drug development** and **experimental cancer therapies** leveraging prodrug activation by the bacterial enzyme[3][4]. Alternative names include **Inosine phosphorylase** and PNP; the gene encoding it in *E. coli* is **deoD**[2]. This enzyme is specific for guanosine, inosine, and adenosine, and its activity is crucial for nucleotide turnover and DNA repair pathways in bacteria[2][3][5][7].

Other names
Inosine phosphorylase2.4.2.1pupdeoD
02

Mechanism of action

Enzyme inhibition (for inhibitors: blockade of purine metabolism by suppressing phosphorolysis of nucleosides) - Enzyme-mediated prodrug activation (in gene therapy, bacterial PNP converts prodrugs to toxic metabolites in tumor cells[3])

03

Biological functions

Purine metabolismPurine nucleoside catabolic processPurine salvage pathwayCellular response to DNA damage stimulus
04

Disease associations

Cancer (as a tool for gene-directed enzyme prodrug therapy)Infection (bacterial viability and pathogenesis target)
05

Safety considerations

Off-target effects if used in prodrug therapy (possibility of affecting endogenous or commensal bacterial flora or, if human PNP is inadvertently targeted, immunodeficiency)
06

Interacting drugs

Null (no small molecule drugs currently in clinical use targeting bacterial DeoD-type PNP directly; inhibitors and agonists are in research)
07

Biomarkers

Null (no established clinical biomarker use of bacterial PNP DeoD-type)

Beyond the preview

Go deeper on Purine nucleoside phosphorylase DeoD-type (PNP (DeoD-type), PNP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purine nucleoside phosphorylase DeoD-type (PNP (DeoD-type), PNP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call